lifestyle.thenyctimes.com

Author: Spago Nanomedical

Spago Nanomedical Continues Recruitment in The Phase I/IIa Tumorad-01 Study Following Positive DMC Recommendation

March 17, 2026
Spago Nanomedical Strengthens CMC and Supply Capabilities to Support Next Phase of Tumorad Development

March 10, 2026
Spago Nanomedical Year-End Report January-December, 2025

February 11, 2026
Nomination Committee Appointed for Spago Nanomedical’s Annual General Meeting 2026

December 8, 2025